ArticleCureus2025
Significance of a Higher-Than-Expected Resonance at a 2.02 ppm Chemical Shift on 1H-Magnetic Resonance Spectroscopy (1H-MRS) in Neuroimaging.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundN-acetyl aspartate (NAA) is a commonly evaluated neuronal metabolite in PURPOSE: This study sought to identify the neuroimaging substrates with a greater-than-expected prominence of the singlet peak at 2.02 ppm in MATERIALS AND
methodsA retrospective descriptive analysis was performed on the institutional imaging database. The search terms for identifying entities included "elevated NAA", "prominent NAA", and "elevated peak at 2.02 ppm". The clinical and imaging features were recorded for eight cases that fulfilled the search criteria.
resultsEight entities fulfilled the search criteria in retrospective analysis. The conditions were Canavan's disease, Pelizaeus-Merzbacher disease, Pelizaeus-Merzbacher-like disease, Salla's disease, colloid cyst, neurenteric cyst, tumoral cyst, and mucinous adenocarcinoma metastasis. A higher-than-expected/elevated peak at 2.02 ppm chemical shift at the predicted location of NAA in
conclusionAn accentuated 2.02 ppm peak on ¹H-MRS should not be interpreted as NAA-specific without contextual correlation. The chemical shift of 2.02 ppm is a metabolite signature of the methyl protons of the N-acetyl group and provides no further information about attached moieties. The signal may arise from a wide gamut of compounds with N-acetyl groups arising from diverse biochemical substrates in metabolic, cystic, and neoplastic lesions, as elucidated. Awareness of these mimics improves diagnostic accuracy and prevents misinterpretation of spectroscopy findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.